Histone lysine methylation can be removed by proteins containing JmjC domains in a sequence-and methylation state-specific manner. JARID1B, a protein containing PHD and JmjC domains, is a histone demethylase specific for H3K4me2 and H3K4me3 which requires Fe(II) and -ketoglutarate (-KG) as cofactors to remove the methyl group. JARID1B has also been shown to play a critical role in the development of breast cancer. JARID1B contains JmjN, Arid and JmjC domains, a C5HC2 zinc-finger domain and three PHD domains. The first PHD domain (PHD1 JARID1B ; residues 306-360) is located at the N-terminus and is important for both histone demethylase activity and histone-tail recognition of JARID1B. Here, the expression, purification and crystallization of PHD1 JARID1B is reported. A PHD1 JARID1B crystal was grown by the hangingdrop vapour-diffusion method in reservoir solution consisting of 0.1 M HEPES pH 7.0, 2.2 M ammonium sulfate at 277 K. A zinc SAD data set was collected from a PHD1 JARID1B crystal. The diffraction pattern of the PHD1 JARID1B crystal extended to 1.65 Å resolution using synchrotron radiation. The crystal belonged to space group P4 3 , with unit-cell parameters a = 51.7, b = 51.7, c = 36.2 Å .
Introduction
Histone methylation is recognized as an important modification that is linked to chromatin and transcription regulation as well as DNAdamage response. Five lysine (K) residues of histone H3 (H3K4, H3K9, H3K27, H3K36 and H3K79) and Lys20 of histone H4 (H4K20) have been identified to be sites for this modification (Margueron et al., 2005; Zhang & Reinberg, 2001) . In general, methylation at H3K9, H3K27 and H4K20 is associated with transcription repression, and methylation at H3K4, H3K36 and H3K79 is associated with transcription activation (Zhang & Reinberg, 2001; Martin & Zhang, 2005) . The first histone demethylase, LSD1 (lysine-specific demethylase 1), was identified in 2004 (Shi et al., 2004) . To date, two distinct classes of demethylases have been characterized. The first class, represented by LSD1, use FAD as a cofactor through an amineoxidation reaction to remove the lysine methyl group. The second class are the family of JmjC-domain-containing demethylases, which require Fe II and -ketoglutarate (-KG) as cofactors in the demethylation process Whetstine et al., 2006; Tsukada et al., 2006; Cloos et al., 2006; Chen et al., 2006) .
Over 30 human JmjC-domain-containing proteins have been found through analysis of public protein-domain databases (Klose, Kallin et al., 2006; Shin & Janknecht, 2007; Xiang, Zhu, Han, Ye et al., 2007) . Many of these proteins have been identified to be histone lysine demethylases (Lee, Villa et al., 2007; Lan et al., 2007; Christensen et al., 2007; Cloos et al., 2006; Iwase et al., 2007; Klose, Yamane et al., 2006; Klose et al., 2007; Whetstine et al., 2006; Yamane et al., 2007; Agger et al., 2007) . The structures of several representative JmjC-domaincontaining histone lysine demethylase family members, including JMJD2A, PHF8, Kiaa1718 and JHDM1A, have been determined in the apo form or in complex with the substrate peptide and -KG (Horton et al., 2010; Chen et al., 2006 Chen et al., , 2007 Couture et al., 2007; Ng et al., 2007; Yang et al., 2010; Han et al., 2007) . However, no structure has been reported for a member of the JARID1 subgroup which can specifically remove trimethylated histone H3K4.
JARID1-subgroup members are highly conserved from yeast to humans and contain a similar domain architecture comprising JmjN, Arid and JmjC domains, a C5HC2 zinc-finger domain and two or three PHD domains (designated PHD1, PHD2 and PHD3 from the N-terminus to the C-terminus). There are four JARID1-group members in mammals, JARID1A (RBP2), JARID1B (PLU-1), JARID1C (SMCX) and JARID1D (SMCY), which have all been identified to be demethylases for trimethylated and dimethylated H3K4 Christensen et al., 2007; Klose et al., 2007; Tahiliani et al., 2007; Yamane et al., 2007) . The four proteins are all important transcriptional corepressors since they remove the transcription-activating mark trimethylated H3K4. Studies of human malignancies show that JARID1B plays a critical role in the development of breast cancer (Lu et al., 1999; Barrett et al., 2002; Yamane et al., 2007) .
Among the recognizable domains in JARID1B, PHD domains are predicted to be involved in histone-tail recognition. JARID1B contains three PHD domains: PHD1 is the first PHD domain, located between the Arid and JmjC domains, while the PHD2 and PHD3 domains are located at the C-terminus. Recent studies of Lid, a homologue of JARID1B in Drosophila, found that PHD1 is required for demethylase activity towards H3K4me3, while PHD2 and PHD3 are not (Li et al., 2010) . Interestingly, unbiased peptide screening for PHD1 interaction indicates that PHD1 can specifically bind to histone H3, either unmodified or with K9 methylation, suggesting that PHD1 plays an important role in the nucleosome-localization and demethylase activity of JARID1B (Li et al., 2010) . Given the highly conserved sequence homology of PHD1 of Lid and JARID1B (58% identity, 80% homology), PHD1 JARID1B may also be important for the function of JARID1B. We have found that PHD1 JARID1B indeed plays an important role in histone-tail recognition and histone demethylase activity (unpublished data). Here, we report the expression, purification and crystallization of PHD1 JARID1B . The structure will reveal the mechanism of histone-tail recognition by PHD1 JARID1B .
Materials and methods

Protein expression and purification
The ORF of PHD1 JARID1B (residues 306-360 of JARID1B; NP_006609.3; Homo sapiens) was engineered into modified pGEX-6P-1 vector (GE Healthcare) using BamHI and XhoI restriction sites. The construct was verified by DNA sequencing and the plasmid was transformed into Escherichia coli strain BL21 (DE3) competent cells. The transformants were grown at 310 K to an OD 600 of 1.0 in Luria broth medium containing 100 mg ml À1 ampicillin and were induced by the addition of 0.2 mM isopropyl -d-1-thiogalactopyranoside. PHD1 JARID1B was overexpressed as a fusion protein with a GST tag at the N-terminus. After a further 12 h incubation at 288 K, the cells were pelleted and resuspended in lysis buffer consisting of 25 mM Tris pH 8.0, 150 mM NaCl supplemented with DNAse and protease inhibitors. Cells were lysed on ice using a French press and the solution was clarified by centrifugation at 15 000 rev min À1 for 30 min at 277 K. The supernatant was applied onto a Glutathione Sepharose 4B column (1 ml resin per column; GE Healthcare) equilibrated with lysis buffer. After washing with buffer containing 25 mM Tris pH 8.0, 150 mM NaCl, the fusion protein was digested on the column with PreScission (3C) protease overnight at 277 K. The molecular weight of PHD1 JARID1B is 6.1 kDa including the additional Gly-Pro-Leu-Gly-Ser sequence from 3C cleavage. The eluted protein was then loaded onto an Source 15Q anion-exchange column (GE Healthcare) and eluted with a linear gradient of 0-0.5 M NaCl at a flow rate of 10 ml min À1 . The peak fractions were collected and further purified by gel-filtration chromatography on a Superdex 200 10/300 GL column (GE Healthcare) with buffer consisting of 10 mM Tris pH 8.0, 50 mM NaCl and 3 mM DTT. PHD1 JARID1B -containing fractions were concentrated to 40 mg ml À1 using an ultracentrifugal filter tube (Millipore) and used for crystallization.
Protein crystallization
Initial crystallization trials were performed using Crystal Screen, Index, SaltRX and PEG/Ion kits from Hampton Research and Wizard I and II kits from Emerald BioSystems at 277 K. These initial screens were set up using the hanging-drop vapour-diffusion method by mixing 1 ml protein solution and 1 ml reservoir solution. the pH, protein concentration, precipitants and additives. Approximately 200 conditions were set up to optimize crystallization.
Data collection and processing
All crystals were mounted in nylon loops and flash-cooled in liquid nitrogen using the reservoir buffer as cryoprotectant. Data collection was carried out on BL17U at Shanghai Synchrotron Radiation Facility (SSRF, People's Republic of China) using a MAR CCD MX-225 detector. The wavelength of the radiation was 1.2823 Å and the crystal-to-detector distance was 90 mm. The exposure time for each frame was 1 s with 1 oscillation and 180 frames were collected. The data were indexed, integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997).
Results and discussion
Recombinant PHD1 JARID1B protein was expressed, purified to homogeneity (Fig. 1) and used for crystallization. The purified PHD1 JARID1B protein was estimated to have a purity of >95% (inset in Fig. 1b) . Initial screening was performed at 277 K and crystals appeared in several conditions as clusters of needle-shaped crystals of about 0.02 mm in width. Most of the initial crystallization conditions contained ammonium sulfate, which was chosen to be the essential component for further optimization. After a further optimization screen of solution buffer pH, precipitants and additives, we obtained crystals that were suitable for diffraction. The crystals (Fig. 2) used for data collection were obtained by mixing 1 ml protein solution (40 mg ml À1 ) with 1 ml reservoir solution consisting of 0.1 M HEPES pH 7.0, 2.2 M ammonium sulfate at 277 K. The crystals appeared after four weeks.
All PHD domains contain two or three Zn atoms according to their primary sequences. In order to solve the phase problem, anomalous data at a wavelength of 1.2823 Å were collected for zinc SAD (Fig. 3) . The diffraction extended to 1.65 Å resolution. The crystals belonged to space group P4 3 , with unit-cell parameters a = 51.7, b = 51.7, Yokoyama, unpublished work) shows 81% sequence similarity and 57% identity to PHD1 JARID1B . Therefore, it should be possible to solve the PHD1 JARID1B structure by molecular replacement.
The crystal structure of PHD1 JARID1B will deepen our understanding of the molecular mechanism of histone-tail recognition by JARID1B.
